GW PHARMACEUTICALS PLC's ticker is GWPH and the CUSIP is 36197T103. A total of 280 filers reported holding GW PHARMACEUTICALS PLC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $10,788,000 | +18.5% | 93,473 | 0.0% | 0.11% | +5.9% |
| Q3 2020 | $9,100,000 | -20.7% | 93,473 | 0.0% | 0.10% | -23.9% |
| Q2 2020 | $11,471,000 | +40.1% | 93,473 | 0.0% | 0.13% | +17.5% |
| Q1 2020 | $8,185,000 | -16.3% | 93,473 | 0.0% | 0.11% | -2.6% |
| Q4 2019 | $9,774,000 | +262.0% | 93,473 | +298.2% | 0.12% | +244.1% |
| Q3 2019 | $2,700,000 | -33.3% | 23,473 | 0.0% | 0.03% | -32.0% |
| Q2 2019 | $4,047,000 | +2.3% | 23,473 | 0.0% | 0.05% | 0.0% |
| Q1 2019 | $3,957,000 | +58.1% | 23,473 | -8.7% | 0.05% | +38.9% |
| Q4 2018 | $2,503,000 | -57.5% | 25,702 | -24.6% | 0.04% | -52.6% |
| Q3 2018 | $5,888,000 | +32.5% | 34,088 | +7.0% | 0.08% | +22.6% |
| Q2 2018 | $4,445,000 | +53.4% | 31,858 | +23.9% | 0.06% | +40.9% |
| Q1 2018 | $2,897,000 | -24.8% | 25,710 | -11.9% | 0.04% | -21.4% |
| Q4 2017 | $3,853,000 | +19.1% | 29,190 | -8.4% | 0.06% | +21.7% |
| Q3 2017 | $3,234,000 | +19.0% | 31,863 | +17.6% | 0.05% | +12.2% |
| Q2 2017 | $2,717,000 | -2.4% | 27,098 | +17.7% | 0.04% | -12.8% |
| Q1 2017 | $2,785,000 | +19.7% | 23,026 | +10.6% | 0.05% | +4.4% |
| Q4 2016 | $2,327,000 | -40.6% | 20,824 | -29.4% | 0.04% | -34.8% |
| Q3 2016 | $3,916,000 | +271.9% | 29,500 | +156.5% | 0.07% | +245.0% |
| Q2 2016 | $1,053,000 | – | 11,500 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|